PTGX icon

Protagonist Therapeutics
PTGX

Overview Fund Activity

138 hedge funds and large institutions have $2.15B invested in Protagonist Therapeutics in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 36 reducing their positions, and 15 closing their positions.

Holders
138
Holders Change
+11
Holders Change %
+8.66%
% of All Funds
2.41%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
26
Increased
60
Reduced
36
Closed
15
Calls
$1.11M
Puts
$2.35M
Net Calls
-$1.24M
Net Calls Change
-$926K

Top Buyers

1
Victory Capital Management
1
Victory Capital Management
Texas
$37.9M
2
Deutsche Bank
2
Deutsche Bank
Germany
$36.9M
3
CCM
3
Consonance Capital Management
New York
$155M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$319M
5
Loomis, Sayles & Company
5
Loomis, Sayles & Company
Massachusetts
$24.1M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$20.4M
2
NHAS
2
Novo Holdings A/S
Denmark
$26.9M
3
State Street
3
State Street
Massachusetts
$65.3M
4
SI
4
Sofinnova Investments
California
$20.2M
5
BI
5
BVF Inc
California
$168M
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
$17.6M -$996K -22,191 -5%
RCAMU
27
Rothschild & Co Asset Management US
Connecticut
$17.4M -$2.07M -46,021 -11%
TLP
28
Tri Locum Partners
New York
$15.3M +$3.8M +84,564 +33%
LCM
29
Laurion Capital Management
New York
$15.1M +$8.51M +189,704 +129%
OM
30
Opaleye Management
Massachusetts
$14.8M +$1.49M +33,222 +11%
SFM
31
Sphera Funds Management
Israel
$13.6M +$4.53M +100,831 +50%
ACM
32
Altium Capital Management
New York
$12.7M +$1.98M +44,091 +18%
Charles Schwab
33
Charles Schwab
California
$12.6M +$888K +19,791 +8%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$11.5M -$4.07M -90,600 -26%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$11.1M +$2.12M +47,255 +24%
CC
36
Commodore Capital
New York
$9.45M -$6.24M -139,000 -40%
PCM
37
Pinz Capital Management
New York
$8.8M +$8.8M +196,000 New
IBT
38
International Biotechnology Trust
United Kingdom
$6.81M – – –
Bank of New York Mellon
39
Bank of New York Mellon
New York
$6.57M +$572K +12,735 +10%
TLCM
40
Twin Lakes Capital Management
California
$6.44M +$25K +556 +0.4%
AAA
41
Affinity Asset Advisors
New York
$6.29M +$4.04M +90,100 +180%
Lord, Abbett & Co
42
Lord, Abbett & Co
New Jersey
$6.22M +$6.22M +138,608 New
PAM
43
Panagora Asset Management
Massachusetts
$6.16M -$4.14M -92,315 -40%
PHP
44
Parkman Healthcare Partners
Connecticut
$5.83M +$5.83M +130,000 New
SAM
45
Silvercrest Asset Management
New York
$5.36M +$5.36M +119,391 New
SEI Investments
46
SEI Investments
Pennsylvania
$4.78M +$882K +19,654 +23%
EA
47
Emerald Advisers
Pennsylvania
$4.66M +$4.66M +103,850 New
EI
48
EAM Investors
California
$4.53M +$4.53M +101,019 New
ICM
49
ISZO Capital Management
New York
$4.21M +$4.21M +93,883 New
Swiss National Bank
50
Swiss National Bank
Switzerland
$3.9M +$144K +3,200 +4%
1
2
3 4 5